Bright Minds Biosciences (DRUG) Other Non Operating Income (2020 - 2026)
Bright Minds Biosciences (DRUG) has disclosed Other Non Operating Income for 2 consecutive years, with -$1.6 million as the latest value for Q1 2026.
- Other Non Operating Income reached -$1.6 million in Q1 2026 per DRUG's latest filing, down from $75047.5 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $75047.5 in Q1 2025 and bottomed at -$1.6 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Bright Minds Biosciences | 464.72 Mn | 405.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.58 Mn |
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | -477,046.78 |
| Jun 30, 2025 | 1.93 Mn |
| Mar 31, 2025 | 75,047.45 |
| Dec 31, 2024 | -1.17 Mn |
| Sep 30, 2024 | -22,347.87 |
| Jun 30, 2024 | 14,495.59 |
| Mar 31, 2024 | 11,932.44 |
| Dec 31, 2023 | 31,067.18 |
| Sep 30, 2023 | 98,670.94 |
| Jun 30, 2023 | 7,523.44 |
| Mar 31, 2023 | -2,585.24 |
| Dec 31, 2022 | 27,356.73 |
| Sep 30, 2022 | -149,681.14 |
| Jun 30, 2022 | -3,351.49 |
| Mar 31, 2022 | 8,057.39 |
| Dec 31, 2021 | 27,042.45 |
| Sep 30, 2021 | 165,685.98 |
| Jun 30, 2021 | 92,791.72 |
| Mar 31, 2021 | 21,305.02 |
| Dec 31, 2020 | 25,027.46 |